Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/08

Curator: Joiejoie

Revision editor(s): Joiejoie, Mautin, Anne-mariesharp, Ese

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Constipation Constipation,Costiveness,Dyschezia,constipation
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Normal (Healthy mice)
Group 1 name Corresponds to the case (exposed) group for case-control studies
CMB2 (Constipation mice treated with CMB2 with no adhesion properties)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 10^10 CFU/mL CMB2(Combined multiple strains of Bifidobacterium with no adhesion property), respectively, daily for 2 weeks and loperamide (0.25 mL) intragastrically from day 15 to day 17 to induce constipation.
Group 0 sample size Number of subjects in the control (unexposed) group
8
Group 1 sample size Number of subjects in the case (exposed) group
8

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
log transformation
Statistical test
ANOVA
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05

Alpha Diversity

Chao1 Abundance-based estimator of species richness
decreased
Richness Number of species
decreased
Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
decreased

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/08

Curator: Joiejoie

Revision editor(s): Joiejoie, Mautin, Anne-mariesharp

Source: Fig. 3, 4 & 5

Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB

Abundance in Group 1: increased abundance in CMB2 (Constipation mice treated with CMB2 with no adhesion properties)

NCBI Quality ControlLinks
Anaeroplasma
Bifidobacterium
Odoribacter
unclassified Helicobacteraceae
Alistipes

Revision editor(s): Joiejoie, Mautin, Anne-mariesharp

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/21

Curator: Joiejoie

Revision editor(s): Joiejoie, Anne-mariesharp

Source: Fig. 3, 4 & 5

Description: Relative abundance (%) of fecal microbial taxa at the genus level in constipated mice fed CMB

Abundance in Group 1: decreased abundance in CMB2 (Constipation mice treated with CMB2 with no adhesion properties)

NCBI Quality ControlLinks
Prevotella
unclassified Lachnospiraceae
Lactobacillus
Turicibacter
Oscillibacter
Ruminococcus
Sporobacter

Revision editor(s): Joiejoie, Anne-mariesharp